1 Mukherjee PK, Horwitz BA, Herrera-Estrella A, Schmoll M, Kenerley CM. Trichoderma Research in the Genome Era. Annu Rev Phytopathol 2013; 51:105–29.
2 Qin W T, Zhuang W Y. Seven wood-inhabiting new species of the genus Trichoderma (Fungi, Ascomycota) in Viride clade. Sci Reps, 2016; 6: 27074.
3 Sun J, Pei Y, Li E, Li W, Hyde KD, Yin W-B, Liu X-Z. A new species of Trichoderma hypoxylon harbours abundant secondary metabolites Sci. Reps , 2016; 6: 37369.
4 Jaklitsch W M , Voglmayr H. Biodiversity of Trichoderma (Hypocreaceae) in Southern Europe and Macaronesia. Stud Mycol, 2015; 80: 1–87.
5 Bissett J, Gams W, Jaklitsch W. Samuels G J. Accepted Trichoderma names in the year 2015. IMA fungus 2015; 6: 263.
6 Cai F, Druzhinina IS. In honor of John Bissett: authoritative guidelines on molecular identification of Trichoderma. Fungal Diver 2021; https://doi.org/10.1007/s13225-020-00464-4
7 Juhász T, Kozma K, Szengyel Z, Réczey K. Production of β-glucosidase by mixed culture
of Aspergillus niger BKMF 1305 and Trichoderma reesei RUT C30. Food Technol Biotechnol 2003; 41(1):49-53.
8 Sivan A, Chet I. Biological control of Fusarium spp. in cotton, wheat and muskmelon by
Trichoderma harzianum. J Phytopathol 1986; 116; 39-47.
9 Naár Z, Kecskés M . A method for selecting Trichoderma strains antagonistic against Sclerotinia minor. Microbiol Res 1995; 150: 239-246.
10 Naseby DC, Pascual JA, Lynch JM. Effect of biocontrol strains of Trichoderma on plant
growth, Pythium ultimum populations, soil microbial communities and soil enzyme activities. J Appl Microbiol 2000; 88: 161-169.
11 Ghosh SK, Banerjee S, Sengupta C. Bioassay, characterization and estimation of siderophores from some important antagonistic fungi. J Biopest 2017; 10: 105 –112.
12 Ghosh SK, Banerjee S, Pal S, Chakrabarty N. Encountering epidemic effects of leaf spot disease (Alternaria brassicae) on Aloe vera by fungal biocontrol agents in agrifields - an ecofriendly approach. PLoS ONE 2018; 13(3): e0193720.
13 Ghosh SK, Bera T, Chakrabarty AM. Microbial siderophore – A boon to agricultural sciences Biological Control 2020; 144: 104214.
14 Ghosh SK, Panja A. Signatures of signaling pathways underlying plant growth promotion by fungi. Chapter :13: 331-327 in: (edit: Jogaiah S, Singh HB, Fraceto L, Lima R) Biocontrol Agents And Secondary Metabolites: Applications In Plant Growth And Protection, 2020a; https://doi.org/10.1016/B978-0-12-822919-4.00013-2, Elsviers, pp 728.
15 Ghosh SK, Panja A. Molecular mechanisms /cell signaling pathways for plant protection from diseases by fungi: Chapter 26:591-612 in : (edit : Jogaiah S, Singh HB, Fraceto L, Lima) Biocontrol Agents and Secondary Metabolites: Applications In Plant Growth And Protection. 2020b ; https://doi.org/10.1016/B978-0-12-822919-4.00013-2, Elsviers .pp728.
16 Papavizas GC. Trichoderma and Gliocladium: biology, ecology, and potential for biocontrol.
Annu Rev Phytopathol 1985; 23: 23-54.
17 Hatvani L, Manczinger L, Vágvölgyi C, Kredics L. Trichoderma as a Human Pathogen, Chapter: 17 In: Trichoderma - Biology and Applications, (Edit: Mukherjee PK, Horwitz BA, Singh US, Mukherjee M, Schmoll M ) Ist edn, 2019a; CAB.
18 van Baarlen P, van Belkum A, Summerbell RC, Crous PW and Thomma BPHJ. Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross - kingdom host jumps? FEMS Microbiol Rev 2007; 31: 239–277.
19 Alanio A, Brethon B, de Chauvin MF, de Kerviler E, Leblanc T, Lacroix C, Baruchel A, Menotti J. Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Clin Infect Dis 2008;46:116–18.
20 Druzhinina IS, Komon ́-Zelazowska M, Kredics L, Hatvani L , Antal Z, Belayneh T , Kubicek CP. Alternative reproductive strategies of Hypocrea orientalis and genetically close but clonal Trichoderma longibrachiatum, both capable of causing invasive mycoses of humans. Microbiology 2008; 154:3447–3459.
21 Kredics L, Antal Z, Dóczi I, Manczinger L L, Kevei F, Nagy E. Clinical Importance Of The Genus Trichoderma - A Review Acta Microbiologica Et Immunologica Hungarica Doi: 10.1556/Amicr. 50.2003.2-3.1
22 Ravi kant, Kaur T, Gupte S, Mandip K. A review on emerging fungal infections and their significance. J Bacteriol Mycol Open Access 2015;1(2):39-41.
23 Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002; 35 (11): 1360–67.
24 Kratzer C, Tobudic S, Schmoll M, Graninger W, Georgopoulos A. In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp. J Antimicrob Chemother 2006; 58, 1058–1061.
25 Menzies JG. A strain of Trichoderma viride pathogenic to germinating seedlings of cucumber, pepper and tomato. Plant Pathol 1993; 42: 784–791.
26 McFadden AG, Sutton JC. Relationships of populations of Trichoderma spp. in soil to disease in maize. Can J Plant Sci 1975; 55: 579–586.
27 Farr DF, Bills GF, Chamuris GP, Rossman AY. Fungi on plants and plant products in the United States. APS Press, St. Paul, Minnesota, USA, 1889; 999.
28 Seaby D. Trichoderma as a weed and pathogen in mushroom cultivation. In: Kubicek, C.P. & Harman, G.E. (eds.), Trichoderma and Gliocladium. Vol. 2. Enzymes, Biological Control and Commercial Applications 1998; 267–283, Taylor and Francis Ltd., London, UK.
29 Howell CR, Puckhaber LS. A study of the characteristics of ―p‖ and ―Q‖ strains of Trichoderma virnes to account for differences in biological control efficacy against cotton seedling diseases. Biol Control 2005; 33: 217–222.
30. Ram RM and Singh HB. Trichoderma spp.: An opportunistic pathogen. Biotech Today 2018; 8 (2): 16-24.
31 Sandoval-Denis M, Sutton DA, Cano-Lira JF, Gené J, Fothergill AW, Wiederhold NP, Guarro J. Phylogeny of the clinically relevant species of the emerging fungus Trichoderma and their antifungal susceptibilities. J Clinmicrobiol 2014; 52(6): 2112-2125
32 Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens Clinical Microbiol Infection 2004;10 ( Supplement 1) : 48-58.
33. Klein D, Eveleigh E. Ecology of Trichoderma. In : Trichoderma and Gliocladium. Basic Biology, Taxonomy and Genetics. Edit: Kubicek CP, Harman GE Taylor & Francis Ltd., London, UK 1998; 57–74.
34. Harman GE, Howell CR, Viterbo A, Chet I,, Lorito M. Trichoderma species-opportunistic, avirulent plant symbionts. Nature Rev Microbiol 2004; 2:43–56.
35. Thrane U, Poulsen SB, Nirenberg HI, Lieckfeldt E. Identification of Trichoderma strains by image analysis of HPLC chromatograms. FEMS Microbiol Lett 2001; 203: 249–255.
36. Hatvani L, Antal Z, Manczinger L, Szekeres A, Druzhinina IS, Kubicek CP, Nagy A, Nagy E,
Vagvolgyi C, Kredics L. Green mold diseases of Agaricus and Pleurotus spp. are caused by
related but phylogenetically different Trichoderma species. Phytopathol 2007; 97: 532–537.
37. I.S. Druzhinina, M. Komon ́-Zelazowska , L. Kredics, L. Hatvani , Z. Antal, T. Belayneh, C.P. Kubicek, Alternative reproductive strategies of Hypocrea orientalis and genetically close but clonal Trichoderma longibrachiatum, both capable of causing invasive mycoses of humans. Microbiol. 154, 3447–59(2008).
38. Recovery collaborative group (Horby et al. ) Dexamethasone in hospitalised patients with COVID-19: N. Eng. J. Med. 384(8):693-704(2021).
39. Hennequin C, Chouaki T, Pichon JC, Strunski V, Raccurt C. Otitis externa due to Trichoderma longibrachiatum. Eur J Clin Microbiol Infect Dis 2000; 1: 641-42.
40. Pasero D, Sanna S, Liperi C, et al. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection 2020; 17:1 –6.
41. Singh AK, Singh R, Joshi SR, Misra A Mucormycosis in COVID-19: Asystematic review of cases reported worldwide and in India, Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2021; doi: https://doi.org/10.1016/j.dsx.2021.05.019.
42. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, Puri GD, Chakrabarti A, Agarwal R. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case report and systematic review of literature. Mycopathologia 2021; 186 (2): 289–298.
43. Kredics L, Hatvani L, Manczinger L, Vagvolgyi C, Antal Z. Trichoderma. In : Molecular Detection of Human Fungal Pathogens, 2011; 509–526. Edit. D. Liu.: Taylor & Francis Group, London, UK.
44. Hatvani L, Manczinger L, Va´gvo¨lgyi C, Kredics L. Trichoderma as a human pathogen. In: Trichoderma: biology and applications; 2013. 292–313.
45. Molnár-Gábor E, Dóczi I, Hatvani L, Vágvölgyi C, Kredics L. Isolated sinusitis sphenoidalis caused by Trichoderma longibrachiatum in an immunocompetent patient with headache. J Med Microbiol 2013; 62: 1249–52.
46. Rodríguez Peralta LI, Mañas Vera MR, García Delgado MJ et al. Endocarditis caused by
Trichoderma longibrachiatum in a patient receiving home parenteral nutrition. Nutr Hosp 2013; 28:961-64.
47. Tascini C, Cardinali G, Barletta V, Paolo AD , Leonildi A, Zucchelli G , Corte L . Colabella C, Roscini L, Consorte A, Pasticci MB , Menichetti F, Bongiorni MG. First case of Trichoderma longibrachiatum CIED (Cardiac Implantable Electronic Device)-associated endocarditis in a non immunocompromised host: biofilm removal and diagnostic problems in the light of the current literature. Mycopathologia 2016; 181:297-303.
48. Akagi T, Kawamura C, Terasawa N, Yamaguchi K and Kubo K. Suspected Pulmonary Infection withTrichoderma longibrachiatum after Allogeneic Stem Cell Transplantation. Intern Med 2017; 56: 215-19.
49. Piecková E, Globanová M, Pol’anová M et al. Trichoderma citrinoviride Bissett from the section Longibrachiatum caused ulcerative keratitis - A case study. Derma 2017; 17:3- 6.
50.Tanis BC, van der Pijl H, van Ogtrop ML, Kibbelaar RE, Chang PC (1995) Fatal fungal peritonitis by Trichoderma longibrachiatum complicating peritoneal dialysis. Nephrol Dial Transplant 10: 114-16.
51. Seguin P, Degeilh B, Grulois I, Gacouin A, Maugendre S, Dufour T, Dupont B, Camus C. Successful treatment of a brain abscess due to Trichoderma longibrachiatum after surgical resection. Eur J Clin Microbiol Infect Dis 1995; 14: 445–448.
52. Munoz, F. M., Demmler, G. J., Travis, W. R., Odgen, A. K., Rossmann, S. N., Rinaldi,M. G.: Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia.J Clin Microbiol 1997; 35: 499–503.
53. Furukawa H, Kusne S, Sutton DA, Manez R, Carrau R, Nichols L, Abu-Elmagd K, Skedros D, Todo S, Rinaldi MG. Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. Clin Infect Dis 1998; 26: 487-89.
54. Samuels GJ, Petrini O, Kuhls K, Lieckfeldt E, Kubicek CP. The Hypocrea schweinitzii complex and Trichoderma sect. Longibrachiatum. Stud Mycol 1998; 41: 1-54.
55. Richter S, Cormican M G, Pfaller M A, Lee C K, Gingrich R, Rinaldi M G, et al. Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature. J Clin Microbiol 1999; 37: 1154–160.
56. Myoken Y, Sugata T, Fujita Y, Asaoku H, Fujihara M, Mikami Y. Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report. Int J Oral Maxillofac Surg 2002; 31 (6): 688–91.
57. Trabelsi S, Hariga D, Khaled S. First case of Trichoderma longibrachiatum infection in a renal transplant recipient in Tunisia and review of the literature. Tunis Med 2010; 88: 52–57.
58. Salas AFS, Joshi AY, Dhiman N, Banerjee R, Huskins WC, Wengenack NL, Henry NK Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis. J Med Microbiol 2011; 60: 1869–871.
59. Recio R, Meléndez-Carmona M Á, Martín-Higuera M C, Pérez V, LópezE, López-Medrano F, et al. Trichoderma longibrachiatum: an ununsual pathogen of fungal pericarditis. Clin Microbiol Infect 2019; 25:586–87.
60. Robertson M H Fungi in fluids - a hazard of intravenous therapy. J Med Microbiol 1970; 3: 99- 102
61. Escudero Gil MR, Pino Corral E, Munoz R. Pulmonary mycetoma cause by Trichoderma viride. Actas Dermosifiliogr , 1976; 67: 673–80.
62. Loeppky CB, Sprouse RF, Carlson JV,Everett ED (1983) Trichoderma viride peritonitis. South Med J 76: 798-799
63.Warnock DW, Johnson EM. Clinical manifestation and management of hyalohyphomycosis, phaehyphomycosis and other uncommon forms of fungal infection in the compromised patient. In:Warnock DW, Richardson MD (eds): Fungal infection in the compromised patient. Chichester: John Wiley & Sons Ltd, 1991; 248-310.
64.Jacobs F, By B, Bourgeois N, Coremans-Pelseneer J, Florquin S, Depré G, Van de Stadt J, Adler M, Gelin M Thys J P. Trichoderma viride infection in a liver transplant recipient. Mycoses 1992; 35: 301-303.
65. De Miguel D, González PGHR, García-Suárez J, Cuadros J, Bañas MH, Romanyk J, Burgaleta C Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: Report of one case and review of the literature Diag Microbiol and Infect Dis 2005; 53(1):33-7.
66. Guiserix J, Ramdane M, Finielz P, Michault A, Rajaonarivelo P (1996) Trichoderma harzianum peritonitis in peritoneal dialysis. Nephron 74: 473-474.
67.Guarro J, Antolin-Ayala MI, Gene J, Gutierrez-Calzada J, Nieves-Diez C, Ortoneda M. Fatal case of Trichoderma harzianum infection in a renal transplant recipient. J Clin Microbiol 1999; 37: 3751-755.
68 Lu ASK, Celkan T, Cel AY, Mikami Y, Kurugoglu S, Mitani H,Altas K. Fatal Trichoderma harzianum infection in a leukemic pediatric patient. Med Mycol 2009; 47: 207-15.
69. Ragnaud JM, Marceau C, Roche-Bezian MC, Wone C. Infection peritoneale a Trichoderma koningii sur dialyseperitoneale continue ambulatoire. Med Maladies Infect 1984; 7: 402-405.
70. Campos-Herrero MI, Bordes A, Perera A, Ruiz MC, Fernandez A. Trichoderma koningiiperitonitis in a patient undergoing peritoneal dialysis. Clin Microbiol Newslett 1996;18: 150-51.
71. Gautheret A, Dromer F, Bourhis JH., Andremont A Trichoderma pseudokoningii as acause of fatal infection in a bone marrow transplant recipient. Clin Infect Dis, 1995; 20:1063-64.
72.Rota S, Marchesi C, Farina , de Biévre C. Trichoderma pseudokoningii peritonitis in automated peritoneal dialysis patient succesfully treated by early catheter removal. Perit Dial Int 2000; 20:91-94.
73. Kviliute, R., Paskevicius, A., Gulbinovic, J. et al. Nonfatal Trichoderma citrinoviride pneumonia in an acute myeloid leukemia patient. Ann Hematol 2008; 87: 501–502.
74. Piens, M.A., Celard, M., De Monbrison, F., Grando, J.,Vandenesch, F., Mottolese, C., Picot, S. (2004). Trichoderma infection of cerebrospinal fluid shunt device in a non-immune compromised patient. J deMycol Med 2004; 14: 49–51.
75. Ranque S, Garcia-Hermoso D, Michel-Nguyen A, Dumon H. Isolation of Trichoderma atroviride from a liver transplant. J Med Mycol 2008; 18: 234–236.
76. Venugopal PL, Venugopal TL, Giromathi A, Ramakrishna ES, Ilavarasi S. Mycotic keratitis in Madras. Indian J Pathol Microbiol 1989; 32:190–97.
77. Amato JG, Amato VS, Amato Neto V, Heins-Vaccari EM. An AIDS patient with Trichoderma Rev Soc Brasil Med Tropic 2002; 35(3): 269.
78.Bustamante-Labarta MH, Caramutti V, Allende GN, WeinschelbaumE, Torino AF (2000)
Unsuspected embolic fungal endocarditis of an aortic conduit diagnosed by transesophageal
echocardiography. J Am Soc Echocardiogr 2000; 13: 953-54
79. Esel D, Koc AN, Utas C, Karaca N, Bozdemir N Fatal peritonitis due to Trichoderma sp. in a patient undergoing continuous ambulatory peritoneal dialysis. Mycoses , 2003; 46 (1–2): 71–73.
80. Ariese KL. Hulshoff L, Jansen R, van der Voort PHJ. Trichoderma: an unusual bystander in invasive pulmonary aspergillosis. Neth J Crit Care 2013; 17(1): 3-4
81. Festuccia M, Giaccone L, Gay F, Brunello L, Maffini E, Ferrando F, Talamo E, Bocca M D, Serra R, Arbui AB, Bruno B. Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report. Transpl Infect Dis 2014; 16: 653–65.
82. Lagrange-Xelot M, Schlemmer F, Gallien S, Lacroix C, Molina JM. Trichoderma fungaemia in a neutropenic patient with pulmonary cancer and human immunodeficiency virus infection. Clin Microbiol Infect 2008;14 (12): 1190–192.
83. Kredics L, Antal Z, Szekers A, Manczinger L, Doczi I, Kevei F, Nagy E. Production of extracellular proteases by human pathogenic Trichoderma longibrachiatum strains .Acta Microbiol Immunol Hung 2004; 51(3):283-95.
84.Antal Z, Kredics L, Pakarinen J, Do´czi I, Andersson M, Salkinoja-Salonen M, et al. Comparative study of potential virulence factors in human pathogenic and saprophytic Trichoderma longibrachiatum strains. Acta Microbiol Immunol Hung 2005; 52(3):341–50.
85. Kredics L, Antal Z, Manczinger L, Kevei F, Nagy E Proteolytic enzyme profiles of clinical Trichoderma isolates. Acta Microbiol Immunol Hung 2002; 49: 416–17.
86. Antal Z, Kredics L, Dóczi I, Manczinger L, Kevei F, Nagy E. The physiological features ofopportunistic Trichoderma strains. Acta Microbiol Immunol Hung 2002; 49: 393.
87. Banerjee S. Isolation &characterization of soil microflora with PCR based molecular identification and their application as biocontrol of fungal pathogens of two medicinally important plants-Aloe era and Bacopa monnieri for crop improvement PhD thesis, University of Kalyani, West Bengal, India 2017:309
88.Nagamani A, Kunwar IK, Manoharachary C Hand book of soil fungi, IK International Pvt Ltd, New Delhi, 2007; pp 477.
89. Do´czi I, Do´sa E, Varga J, Antal Z, Kredics L, Nagy E. E-test for assessing the susceptibility of filamentous fungi. Acta Microbiol Immunol Hung. 2004; 51(3):271–81.
90. Vicente MF, Cabello A, Platas G, Basilio A, Diez MT, Dreikorn SRA, Giacobbe JC, Onishi M, Kurtz Meinz MB, Rosenbach M, Thompson J, Abruzzo G, Flattery A, Kong L, Tsipouras A, Wilson KE, Pelaez F. Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum. J Appl. Microbiol. 2001; 91 : 806–13.
91. Lux F, Bo &anic D, Bl´ umel G & Erhardt W (1978) Activation-¨analysis investigation of the behaviour of biological trace elements during wound healing: the roles of calcium and iron. Microchim Acta 1: 35–54.
92. Mateos F, Brock JH & Perez-Arellano JL (1998) Iron metabolism´in the lower respiratory tract. Thorax 53: 594–600.
93. Winnenburg R, Baldwin TK, Urban M, Rawlings C, Kohler J &¨Hammond-Kosack KE. PHI-base: a new database for pathogen host interactions. Nucleic Acids Res 2006; 34: D459–D464.
94. Payne SM. Iron acquisition in microbial pathogenesis. Trends Microbiol 1993; 1: 66–69.
95. Byers BR , Arceneaux JE. Microbial iron transport: iron acquisition by pathogenic microorganisms. Metal Ions Biol Syst 1998; 35: 37–66.
96. Wandersman C, Delepelaire P. Bacterial iron sources: from siderophores to hemophores. Annu. Rev Microbiol 2004; 58: 611 –647.
97. Expert D (1999) Withholding and exchanging iron: interactions between Erwinia spp. and their plant hosts. Annu Rev Phytopathol 1999; 37: 307–334.
98.Howard DH . Acquisition, transport and storage of iron by pathogenic fungi. Clin Microbiol Rev 1999; 12: 393–04.
99. Ratledge C, Dover LG. Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 2000; 54: 881–941.
100.Enard C, Diolez A & Expert D. Systemic virulence of Erwinia chrysanthemi 3937 requires a functional iron assimilation system. J Bacteriol 1988; 170: 2419–2426.
101. Franza T, Mahe B , Expert D. Erwinia chrysanthemi requires a second iron transport route dependent of the siderophore achromobactin for extracellular growth and plant infection. Mol Microbiol 2005;55: 261–275.
102.Jung WH, Sham A, White R & Kronstad JW. Iron regulation of the major virulence factors in the AIDSassociated pathogen Cryptococcus neoformans. Plos Biol 2006; 4:e410
103. Zähner H, Keller-Schierlein W, Hütter R, Hess-Leisinger K, Deer A. Stoffwechselprodukte von Mikroorganismen. Arch Microbiol 1963; 45: 119 –135
104.Pal S, Ghosh SK. Diversity of soil fungi in North 24 Parganas and their antagonistic potential against Leucinodes orbonalis Guen. (Shoot and fruit Borer of Brinjal). Environ Monit Assess 2014; 186: 8707-8716.
105. Ghosh SK, Pal S, Chakraborty N. The qualitative and quantitative assay of siderophore production by some microorganisms and effect of different media on its production. Int J Chem Sci 2015;13: 1621 –29
106. Hussein KA, Joo J.H. Potential of siderophore production by bacteria isolated from heavy metal: polluted and rhizosphere soils. Korean J Soil Sci Fert 2012;45, 798 –804.
107. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev (2004) 17(2):255–67. doi:10.1128/CMR.17.2.255- 267.2004.
108. Nobile CJ, Johnson AD. Candida albicans biofims and human disease. Annu Rev Microbiol (2015) 69:71–92. doi:10.1146/annurev-micro-091014- 104330.
109. Beauvais A, Schmidt C, Guadagnini S, Roux P, Perret E, Henry C, et al. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol (2007) 9(6):1588–600.
110. Martinez LR, Christaki E, Casadevall A Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro. J Infect Dis (2006) 194(2):261–6.doi:10.1086/504722.
111. Kernien JF, Snarr BD, Sheppard DC and Nett JE. The Interface between Fungal Biofims and Innate Immunity.Front Immunol 2018; 8:1968.
112. Gravelat FN, Beauvais A, Liu H, Lee MJ, Snarr BD, Chen D, et al. Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal beta-glucan from the immune system. PLoS Pathog 2013; 9(8):e1003575. doi:10.1371/journal.ppat.1003575
113. Lee MJ, Geller AM, Bamford NC, Liu H, Gravelat FN, Snarr BD, et al. Deacetylation of fungal exopolysaccharide mediates adhesion and biofilm formation. M Bio 2016; 7(2):1–14.
114.Triveni S, Prasanna R, Kumar A, Bidyarani N. Evaluating the promise of Trichoderma and Anabaena based biofilms as multifunctional agents in Macrophomina phaseolina ‐infected cotton crop. Biocontrol Sci Technol 2015;25:656 ‐70
115.Triveni S, Prasanna R, Shukla L, Saxena AK. Evaluating the biochemical traits of novel Trichoderma ‐based biofilms for use as plant growth ‐promoting inoculants. Ann Microbiol 2013;63:1147 ‐56.
116. Dreyfuss M, Härri E, Hoffmann H, Kobel H, Pache W, Tscherter H. Cyclosporin A and C. new metabolites from Trichoderma polysporum (Link ex. Pers.) Rifai. Eur J Appl Microbiol 1976;. 3: 125–133.
117. Rodríguez M A, Cabrera G, Godeas A. Cyclosporine A from a nonpathogenic Fusarium oxysporum suppressing Sclerotinia sclerotiorum. J Appl Microbiol 2006; 100, 575–586.
118. Azam A, Anjum T, Irum, W. Trichoderma harzianum: a new fungal source for the production of cyclosporin A. Bangladesh J. Pharmacol 2012; 7: 33–5.
119. Rovira P, Mascarell L, Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr Med Chem 2000; 7: 673–92.
120.Hämäläinen M, Korhonen R, Molianen E. Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA. Int Immunopharmacol 2009; 9: 159–67.
121Borel J F, Feurer C, Gubler H U, Stähelin H. Biological effects of cyclosporin A: a new antilymphocyte agent. Agents Actions 1976; 6: 468–75.
122. Levy G A. Long-term immunosuppression and drug interactions. Liver Transpl. 2001; 7(11 Suppl. 1), S53–S59.
123. Rether J, Serwe A, Anke, T, Erkel G. Inhibition of inducible tumor necrosis factor-alpha expression by the fungal epipolythiodiketopiperazine gliovirin. Biol Chem 2007; 388: 627–37.
124.Lumsden R D, Locke J C, Adkins S T, Walter J F, Ridout C J. Isolation and localization of the antibiotic gliotoxin produced by Gliocladium virens from alginate prill in soil and soilless media. Phytopathol 1992; 82: 230–35.
125. Johannessen L N, Nilsen A M, Løvik M. The mycotoxins citrinin and gliotoxin differentially affect production of the pro-inflammatory cytokines tumour necrosis factor-alpha and interleukin-6, and the antiinflammatory cytokine interleukin-10. Clin. Exp. Allergy 2005; 35: 782–789.
126. Koller B, Müller-Wiefel A S, Rupec R, Korting H C, Ruzicka T. Chitin modulates innate immune responses of keratinocytes. PLoS ONE 2011; 6:e16594. doi: 10.1371/ journal.pone.0016594.
127. Brodaczewska K, Donkow-Lysoniewska K, Doligauska M. Chitin, a key factor in immune regulation: lesson from infection with fungi and chitin bearing parasites. Acta Parasitol 2015; 60: 337–44.
128. Konstantinovas C, de Oliveira Mendes TA, Vannier-Santos MA and Lima-Santos J. Modulation of Human Immune Response by Fungal Biocontrol Agents. Front Microbiol 2017; 8:39.doi: 10.3389/fmicb. 2017.00039
129. Rementeria, A. N. Lopez-Molina , A. Ludwig, A.B. Vivanco, J. Bikandi´, J. Ponton , J. Garaizar, Genes and molecules involved´ in Aspergillus fumigatus virulence. Rev. Iberoam. Micol. 22, 1–23(2005).
130. Fishman JA. Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl. 17, 34–37( 2011).
131. Barle EL, Winkler GC, Ulrich P, Perino C, Kuster M, Probst A, et al. Cancer risk of immunosuppressants in manufacturing. Regul Toxicol Pharmacol 2014; 70: 122–24(2014).
132. Moran GP, Coleman DC , Sullivan DJ . Comparative Genomics and the Evolution of Pathogenicity in Human Pathogenic Fungi. Eukaryot Cell 2011; 1: 34–42(2011).
133. Butler G et al. Evolution of pathogenicity and sexual reproduction ineight Candida genomes. Nature 459, 657–662(2009).
134. Fedorova ND, et al. . Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus. PLoS Genet 2008; 4:e1000046.
135. Hall C , Brachat S, Dietrich FC, Contribution of horizontal gene transfer to the evolution of Saccharomyces cerevisiae. Eukaryot Cell 4, 1102–1115(2005).
136. Khaldi N, Collemare J , Lebrun MH, Wolfe KH. Evidence for horizontal transfer of a secondary metabolite gene cluster between fungi. Genome Biol. 9, R18( 2008).
137. Fitzpatrick D, Logue M, Butler G. Evidence of recent interkingdom horizontal gene transfer between bacteria and Candida parapsilosis. BMC Evol. Biol. 8, 181(2008).
138. Biswas S, Van Dijck P, Datta A, Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol. Mo.l Biol. Rev. 71,348–376 (2007).
139.. Lavoie H, Hogues H, Whiteway M. Rearrangements of the transcriptional regulatory networks of metabolic pathways in fungi. Curr Opin Microbiol. 12, 655–663(2009).
140. Scheffer RP. Role of toxins in evolution and ecology of plant pathogenic fungi. Experientia 47, 804–11(1991).
141. Domsch KH, Gams W, Anderson TH, Compendium of soil Fungi Vol. –I & II, Academic Press, London(1980).
142. Mukherjee PK , Horwitz BA, Kenerley CM. Secondary metabolism in Trichoderma- a genomic perspective. Microbiol. 2012, 158(1): 35-45.
143.Kubicek CP,Mach RI, Peterbauer CK, lzorito M. Trichoderma : From genes to biocontrol. J Plant Pathol, 2011 83(2):11-23.
144. Kubicek CP, Herrera-Estrella A, Seidl-Seiboth V, Martinez DA, Druzhinina IS, et al. Comparative genome sequence analysis underscores mycoparasitism as the ancestral life style of Trichoderma. Genome Biol. 2011;12: R40.
145. Tseng Y-H, Rouina H, Groten K, Rajani P, Furch ACU, Reichelt M,Baldwin IT, Nataraja KN,Uma Shaanker R and Oelmüller R . An endophytic Trichoderma strain promotes growth of its hosts and defends against pathogen attack. Front Plant Sci 2020; 11:573670.doi: 10.3389/fpls.2020.57367.
146. Mukherjee PK. Genomics of biological control- whole genome sequencing of two mycoparasitic Trichoderma spp. Curr. Sci. 2011; 101(3): 268.
147 Podder D, Ghosh SK. A new application of Trichoderma asperellum as an anopheline larvicide for eco friendly management in medical science. Sci Reps , 2019; 9(1): 1108.
148 Ghosh SK, Podder D, Mukherjee A. An insight of anopheline larvicidal mechanism of Trichoderma asperellum (TaspSKGN2). Sci Reps. 2021; 11: 16029 doi.org/10.1038/s41598-021-95310-1
149 Rubin GM, Yandell MD, Wor tman JR et al. Comparative genomics of the eukaryotes. Science 2000; 287: 2204–215.
150 MIPS Arabidopsis thaliana Genome Database, 2006.